Lomotil toxicity: Difference between revisions
No edit summary |
|||
| Line 23: | Line 23: | ||
==Management== | ==Management== | ||
*Maintain airway and support ventilation, if needed | *Maintain airway and support ventilation, if needed | ||
*Naloxone 1-2mg IV for apnea, coma, or lethargy (may require repeat dosing) | *[[Naloxone]] 1-2mg IV for apnea, coma, or lethargy (may require repeat dosing) | ||
* | *[[Activated charcoal]] should be given promptly if available | ||
*No evidence for utility of [[physostigmine]] | |||
==Disposition== | ==Disposition== | ||
Revision as of 21:45, 13 December 2016
Background
- Mixture of diphenoxylate / atropine used to treat diarrhea
- Children are especially sensitive to toxicity (death reported after ingestion of <5 tablets)
Mechanism of toxicity
- Diphenoxylate
- opioid analog of meperidine, which has opioid-like toxicity in overdose
- Atropine
- anticholinergic effects
- Toxic dose is variable
Clinical Features
- Atropine effects
- Lethargy, agitation, flushing, dry mucous membranes, mydriasis, ileus, tachycardia
- Opioid effects
- Miosis, coma, respiratory depression, respiratory arrest
Differential Diagnosis
Evaluation
- Diagnosis is based on history and signs of toxicity
Management
- Maintain airway and support ventilation, if needed
- Naloxone 1-2mg IV for apnea, coma, or lethargy (may require repeat dosing)
- Activated charcoal should be given promptly if available
- No evidence for utility of physostigmine
Disposition
- Pediatric patients should be observed in the ICU for 24 hours given risk of sudden respiratory arrest
See Also
References
- Olson, K. Poisoning and Drug Overdose Clinical Manual. 2004